Tokyo, Japan

Norikazu Otake

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norikazu Otake. Retrieved from https://idiyas.com/inventor/norikazu-otake-mo3345zb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Toshima-ku, JP (2016)
  • Tokyo, JP (2019 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Norikazu Otake

Introduction

Norikazu Otake, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of five patents, Otake's work reflects a commitment to advancing therapeutic solutions for various medical conditions.

Latest Patents

Otake’s latest inventions include a novel method for producing a (2S)-2-[(1H-pyrazol-1-yl)methyl]-1,3-oxazinane derivative. This innovative process enables the synthesis of a compound represented by formula (1), which holds potential in medicinal applications. Additionally, he has developed an amino acid derivative prodrug, which serves as a prodrug form of an amino acid derivative functioning as a group 2 metabotropic glutamate receptor antagonist. This prodrug is significant as it offers therapeutic benefits for a wide array of mood-related disorders, cognitive impairments, and other neurological conditions, showcasing Otake's dedication to improving mental health treatments.

Career Highlights

Otake is currently associated with Taisho Pharmaceutical Co., Ltd., where he actively engages in research and development to bring innovative therapeutic options to the market. His expertise in medicinal chemistry is central to the company’s focus on creating effective pharmaceutical products.

Collaborations

Throughout his career, Otake has collaborated with talented colleagues such as Takashi Hashihayata and Yohei Matsuda. Their collective efforts have been instrumental in advancing the innovative projects at Taisho Pharmaceutical, leading to groundbreaking products that address unmet medical needs.

Conclusion

Norikazu Otake's inventive work continues to have a profound impact within the pharmaceutical industry. His dedication to research and development not only benefits the scientific community but also holds promise for improving the quality of life for patients facing various health challenges. As he continues to innovate, Otake exemplifies the spirit of progress in the world of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…